BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10340381)

  • 1. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis.
    Miyaki M; Iijima T; Konishi M; Sakai K; Ishii A; Yasuno M; Hishima T; Koike M; Shitara N; Iwama T; Utsunomiya J; Kuroki T; Mori T
    Oncogene; 1999 May; 18(20):3098-103. PubMed ID: 10340381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
    Miyaki M; Yamaguchi T; Iijima T; Funata N; Mori T
    Oncology; 2006; 71(1-2):131-5. PubMed ID: 17347589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
    J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No SMAD4 hypermethylation in colorectal cancer.
    Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
    Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of protein-truncating mutations of the p53 gene in liver metastases of colorectal carcinomas.
    Miyaki M; Iijima T; Yasuno M; Kita Y; Hishima T; Kuroki T; Mori T
    Oncogene; 2002 Sep; 21(43):6689-93. PubMed ID: 12242668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
    Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
    Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
    Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
    Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
    Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
    Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer.
    Lu SL; Akiyama Y; Nagasaki H; Saitoh K; Yuasa Y
    Biochem Biophys Res Commun; 1995 Nov; 216(2):452-7. PubMed ID: 7488133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.
    Hohenstein P; Molenaar L; Elsinga J; Morreau H; van der Klift H; Struijk A; Jagmohan-Changur S; Smits R; van Kranen H; van Ommen GJ; Cornelisse C; Devilee P; Fodde R
    Genes Chromosomes Cancer; 2003 Mar; 36(3):273-82. PubMed ID: 12557227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.
    MacGrogan D; Pegram M; Slamon D; Bookstein R
    Oncogene; 1997 Aug; 15(9):1111-4. PubMed ID: 9285566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.
    Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
    Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Fukunari H; Tanaka K; Miyaki M
    Cancer Res; 1992 Jul; 52(13):3801-3. PubMed ID: 1319833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.